US/UK/Canada

Share

Pick a time period -
Tags ( Active)

TOOsonix announces granted patents for its non-invasive treatments of dermatological conditions

TOOsonix A/S secures intellectual property rights in USA, Europe and China. The patents define methods for non-invasive and real-time image-guided treatment of skin using therapeutic ultrasound.Hoersholm, Denmark, November 9[th], 2022 - TOOsonix A/S, a pioneer in high intensity focused ultrasound (HIFU) technology for dermatology, today announced that the United States Patent and Trademark Office (USPTO) has granted a U.S. patent no. 11/491,351 regarding its key technologies. The U.S. patent and already granted patents in Europe and China therefore complete the first phase of securing

FIRST PATIENT WITH BASAL CELL CARCINOMA TREATED IN NEW FOCUSED ULTRASOUND STUDY

The dermatology departments at Bispebjerg and Roskilde Hospitals, University of Copenhagen, Denmark, initiate pioneering treatment of the world’s most common cancer with a new convenient, minimal-pain and easy-to-operate modality for skin oncology.           Hoersholm, Denmark, April 19[th] 2022 - TOOsonix A/S, a pioneer in high intensity focused ultrasound (HIFU) for dermatology, today announced that the first patients with basal cell carcinoma  have been treated in a new clinical study using its System ONE-M device.      Basal Cell Carcinoma (BCC) is the most common cancer in

DERMATOLOGY HIFU PRODUCT RELEASE

TOOsonix CE marks and releases new medical ultrasonic device for color-independent tattoo removal, solar lentigines, spider veins, angiomas, telangiectasia and other aesthetic conditions.Hoersholm, Denmark, June 29[th] 2020 - TOOsonix A/S, a pioneer in HIFU focused ultrasound technology for dermatology, today announce that it has released its System ONE-M as a CE-marked medical device for aesthetic treatments. The release coincides with the publication of two clinical papers in the peer-reviewed scientific journal, Skin Research and Technology (John Wiley and Sons, Inc.), describing very

There are no items matching the current filter
There are no more items matching the current filter
Back to top

Media